| Aarti Pharmalabs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543748 |
NSE Symbol : AARTIPHARM |
P/E(TTM) : 37.24 |
|
ISIN Demat : INE0LRU01027 |
Div & Yield% : 0.41 |
EPS(TTM) : 23.18 |
|
Book Value(₹) : 218.61 |
Market Cap(₹Cr) : 7,827.03 |
Face Value(₹) : 5.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 534.59 | 579.70 | 425.25 | 417.29 | 375.31 | 529.62 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 534.59 | 579.70 | 425.25 | 417.29 | 375.31 | 529.62 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.93 | 10.53 | -0.37 | 3.15 | 1.60 | -2.51 |
| Total Income | 537.52 | 590.23 | 424.88 | 420.44 | 376.91 | 527.12 |
| Total Expenditure | 398.39 | 462.63 | 325.10 | 343.31 | 280.18 | 386.50 |
| PBIDT | 139.13 | 127.60 | 99.78 | 77.13 | 96.73 | 140.62 |
| Interest | 12.87 | 16.86 | 12.58 | 10.66 | 6.79 | 6.29 |
| PBDT | 126.25 | 110.74 | 87.20 | 66.47 | 89.93 | 134.33 |
| Depreciation | 30.03 | 28.16 | 28.62 | 24.77 | 22.76 | 20.83 |
| Tax | 20.14 | 18.06 | 9.11 | 2.20 | 12.62 | 14.84 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 4.78 | 2.50 | 5.63 | 8.57 | 3.33 | 9.82 |
| Reported Profit After Tax | 71.31 | 62.03 | 43.84 | 30.93 | 51.22 | 88.85 |
| Extra-ordinary Items | 0.00 | 0.00 | -2.09 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 71.31 | 62.03 | 45.93 | 30.93 | 51.22 | 88.85 |
| EPS (Unit Curr.) | 7.87 | 6.84 | 4.84 | 3.41 | 5.65 | 9.80 |
| EPS (Adj) (Unit Curr.) | 7.87 | 6.84 | 4.84 | 3.41 | 5.65 | 9.80 |
| Calculated EPS (Unit Curr.) | 7.86 | 6.84 | 4.84 | 3.41 | 5.65 | 9.80 |
| Calculated EPS (Adj) (Unit Curr.) | 7.86 | 6.84 | 4.84 | 3.41 | 5.65 | 9.80 |
| Calculated EPS (Ann.) (Unit Curr.) | 31.45 | 27.37 | 19.35 | 13.65 | 22.61 | 39.21 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 31.45 | 27.37 | 19.35 | 13.65 | 22.61 | 39.21 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 30.00 | 0.00 | 0.00 | 0.00 |
| Equity | 45.34 | 45.32 | 45.32 | 45.32 | 45.32 | 45.32 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 26.03 | 22.01 | 23.46 | 18.48 | 25.77 | 26.55 |
| PBDTM(%) | 23.62 | 19.10 | 20.51 | 15.93 | 23.96 | 25.36 |
| PATM(%) | 13.34 | 10.70 | 10.31 | 7.41 | 13.65 | 16.78 |
